Dr. Jaime Lynne Bohl, MD

Dr. Bohl practices at VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia.

Dr. Bohl's NPI, 1487701272, was assigned on January 4, 2007. Dr. Bohl graduated from UVA School of Medicine in 2003. Dr. Bohl holds Virginia license 0101261479.

Dr. Bohl's primary practice is VCU Medical Center, at 1250 East Marshall Street, Richmond, VA 23298 in Richmond City. The practice phone is (804) 828-9000.

Dr. Bohl's primary practice is VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia. Dr. Bohl is also affiliated with VCU Health Tappahannock Hospital. The medical group on file is MCV Physicians. Dmand AI also links Dr. Bohl to 1 more group practice or clinic and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bohl practices, 4 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Bohl's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Bohl is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Bohl's licenses on file in 3 states: Virginia, North Carolina and Louisiana.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Bohl treats.

CMS data shows 204 Medicare services from Dr. Bohl across 9 procedure codes in 2024, for 186 Medicare patients. Medicare paid $22,415 for them.

CMS counts 186 Medicare patients who saw Dr. Bohl in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bohl's median patient age at 66, with 54% women.

In 2024, Dr. Bohl wrote 108 Medicare Part D claims for 48 patients. 100% of them were for generic drugs. CMS names the drug for 68 of them, across 3 drugs with 11 or more claims each, at $148 in total drug cost. In 2023, CMS named 55 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Bohl for performance year 2024, reported as part of a group. Dr. Bohl accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 27 procedures of colonoscopy by Dr. Bohl, more than 52% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. Bohl, published from 2007 to 2025. 2016 was the busiest year, with 2. The most frequent topics are Colorectal Neoplasms, Anal Canal and Colectomy. Dr. Bohl has published most often in Am Surg. Dr. Bohl's most frequent co-authors are Stephen J. Bickston, MD, Emily Burke Rivet, MD and Yahya Ahmed Adnan Alwatari, MD.

Dmand AI links Dr. Bohl to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Adenomatous Polyps, Colitis, Ulcerative and Fecal Incontinence.

CMS Open Payments shows 60 general payments to Dr. Bohl from 6 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 45% of the total. Intuitive Surgical, Inc. paid the most, $8,695.

Dmand AI lists 3 awards for Dr. Bohl, most recently CMS Stage 1 EHR in 2012.

Dr. Bohl graduated from UVA School of Medicine in 2003. Dr. Bohl is a member of ACS.

Dr. Bohl is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.